Rezolute, Inc.
NASDAQ:RZLTBiotechnology
+$0.30 today
- Market cap
- $411.10M
- Beta
- 0.65
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$0.78
Volume 2.93M
Average 2.03M
RZLT Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Rezolute, Inc.NASDAQ: RZLT
Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Mar 2026
Weighted avg shares (diluted) grows, but more slowly than its trailing trend
Q3 FY2026 weighted avg shares (diluted) of 104.04M shares rose 48.6% year over year, behind the +55.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.3% from the prior quarter. Over 3 fiscal years it compounded at +57.4% a year.
Context
- Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +48.6% toward the trailing-twelve-month pace of +55.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 76M USD
- Year-over-year change
- +47.7%
- 4-year CAGR
- +77.4%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 76M | +47.7% |
| FY2024 | 2024-06-30 | 51.47M | +0.5% |
| FY2023 | 2023-06-30 | 51.19M | +162.7% |
| FY2022 | 2022-06-30 | 19.49M | +154.0% |
| FY2021 | 2021-06-30 | 7.67M | — |
Weighted Avg Shares (Diluted) vs competitors
How RZLT compares with its peers on the latest reported figures
- RZLT's LTM Mar 2026 weighted avg shares (diluted) of 101.37M shares is the highest of the 5 companies compared; the peer median is 63.69M shares.
- Its year-over-year change of +55.6% is the highest of 5, against a peer median of +3.2%.
- Over three fiscal years its annual growth of +57.4% compares with a peer median of +12.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 101.37M | +55.6% | +57.4% | |
| LTM Mar 2026 | 99.68M | +6.6% | +12.1% | |
| LTM Mar 2026 | 69.93M | -1.6% | -5.4% | |
| LTM Mar 2026 | 57.44M | +16.4% | +18.4% | |
| LTM Mar 2026 | 5.55M | -0.3% | +12.3% | |
| Peer median (excluding RZLT) | 63.69M | +3.2% | +12.2% | |
Competitors are the stored peer set for RZLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 13K | 0 | 0 | 0 | 0 |
| Gross Profit | (13K) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 14.99M | 32.49M | 43.81M | 55.74M | 61.53M |
| Selling, General & Admin | 7.91M | 9.36M | 12.18M | 14.68M | 18.37M |
| Operating Expenses | 22.88M | 41.84M | 55.99M | 70.42M | 79.89M |
| Depreciation & Amortization | 13K | 13K | 30K | 36K | 31K |
| EBITDA | (20.51M) | (39.24M) | (51.76M) | (68.42M) | (74.38M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (22.89M) | (41.84M) | (55.99M) | (70.42M) | (79.89M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 63K | 80K | 4.21M | 4.87M | 5.48M |
| Interest Expense | 375K | 1.81M | 0 | 0 | 0 |
| Other Income / Expenses | 1.99M | 783K | 4.2M | 1.96M | 5.48M |
| Income Before Tax | (20.9M) | (41.06M) | (51.79M) | (68.46M) | (74.41M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (20.9M) | (41.06M) | (51.79M) | (68.46M) | (74.41M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (2.72) | (2.26) | (1.01) | (1.33) | (0.98) |
| EPS (Diluted) | (2.72) | (2.32) | (1.01) | (1.33) | (0.98) |
| Weighted Avg Shares | 7.67M | 18.2M | 51.19M | 51.47M | 76M |
| Weighted Avg Shares (Diluted) | 7.67M | 19.49M | 51.19M | 51.47M | 76M |
Rezolute, Inc.
NASDAQ:RZLT
Intrinsic Alpha fair value
Locked
Current Price
$4.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.